Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Diabetology & Metabolic Syndrome

Figure 1

From: Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study

Figure 1

Effect of fenofibrate on brachial artery diameter in basal conditions and during hyperemia at 45, 60, 90 and 120 seconds. *Statistically significant difference in mean brachial artery diameter pre- and post-treatment. Error bars represent 95% confidence intervals Basal, before hyperemia; 45 s, hyperemia 45 s; 60 s, hyperemia 60 s; 90 s, hyperemia 90 s; 120 s, hyperemia 120 s.

Back to article page